Caplin Point Laboratories Ltd, via its subsidiary Caplin Steriles, has acquired 10 approved ANDAs for injectable and ophthalmic products in the U.S. The acquisition strengthens its regulated market portfolio, complements recent USFDA approvals, and positions the company for accelerated growth in the U.S. generics and specialty pharma space.
Show moreStay Ahead – Explore Now! Microsoft’s $80 Billion Bet: Nadella Takes the Wheel as Product Manager
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
